Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1986-11-7
pubmed:abstractText
Mechanically harvested lymphocytes invading an irreversibly rejected human kidney allograft were seeded at limiting dilution to calculate the frequency of growing precursors. Optimal growth frequency (1/13) was obtained when Epstein-Barr virus (EBV)-transformed donor B lymphocytes were used as stimulators (D-BLCL) in the presence of interleukin 2 (IL-2). The 55 clones analyzed were all T11+ and T3+, and all expressed DR antigens (45% were T8+ and 55% T4+). Only one clone had a double-labeled (T4+ T8+) surface. All cells proliferated significantly against D-BLCL, although T4+ clones had a significantly shorter average doubling time than T8+ clones. Nearly all T8+ clones were specifically cytotoxic for D-BLCL, while both T4 and T8 did not react against K562, autologous EBV-BLCL, and third-party EBV-BLCL. Detectable IL-2 was found in the culture supernatants of only a minority of clones (all T4+).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-1093024, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-2408366, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-2930916, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-2985701, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-2996186, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-3155462, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-325134, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-3969720, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-4333982, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-4610924, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6190908, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6197484, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6208657, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6220816, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6231642, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6340271, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6342225, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6345671, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6348936, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6362144, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6377614, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6600474, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6609996, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-6985405, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-7019377, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020092-7033436
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
874-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.
pubmed:publicationType
Journal Article